Retrospective analysis of a neoadjuvant radiochemotherapy / radioimmumotherapy in patients with advanced squamous cell carcinoma of the oral cavity

Retrospective analysis of a neoadjuvant radiochemotherapy / radioimmumotherapy in patients with advanced squamous cell carcinoma of the oral cavity - RARASO

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026793

Enrollment

Registered

2021-10-04

Start date

2021-09-27

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C02 C06

Interventions

Group 1: Examinations during routine clinical follow up every 3 to 6 months.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients initially assessed not being eligible for resection by the treating surgeon who had received neoadjuvant treatmeant.

Exclusion criteria

Exclusion criteria: for retrospective analysis: none

Design outcomes

Primary

Measure	Time frame
relapse free survival	—

Secondary

Measure	Time frame
Quality of life	—

Countries

Germany

Contacts

Public ContactGunnar Lohm

Johanniter-Krankenhaus Genthin-Stendal

gunnar.lohm@sdl.johanniter-kliniken.de03931661500

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026